EUVIMEDEUVIMED entdecken
Kontrollierte klinische StudieMultizentrische StudieStudienprotokoll

Impact of a Treatment Protocol for Hospitalized Adults With Acute Immune Thrombocytopenia

Justin Presutto iD, Abby Rose Broomfield, Sierra Parsons, Morgan LaMarc, Andre McMahon, Bren Magruder

Annals of Pharmacotherapy · 2026

DOI: 10.1177/10600280251338604 ↗

Kurz gefasst

Kontrollierte klinische Studie in der Zeitschrift Annals of Pharmacotherapy, 2026. Verfasst von Justin Presutto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Services, Sarasota Memorial Health Care System, Sarasota Memorial Hospital, Sarasota, FL, USA. Hauptthemen laut MEDLINE: Clinical Protocols, Purpura, Thrombocytopenic, Idiopathic. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Definitive management of acute immune thrombocytopenia (ITP) in hospitalized patients remains variable. A lack of standardized treatment protocols has led to varying treatment sequences and inconsistent utilization of resources. A viable remedy exists in developing a standardized sequential treatment protocol balancing therapeutic efficacy with financial responsibility.

Objective

The purpose of this study was to evaluate the pharmacoeconomic impact and clinical efficacy of an inpatient pharmacist-developed sequential ITP treatment protocol. The primary objective was to evaluate drug cost of ITP treatment per patient pre- versus post-protocol implementation. Secondary objectives included hospital length of stay and platelet count at discharge.

Methods

This multicenter, retrospective, quasi-experimental, institutional review board-approved study assessed hospitalized patients treated for acute ITP between October 2018 and June 2023 at Sarasota Memorial Health Care System. The ITP protocol was implemented on June 1, 2022. Retrospective chart review was performed on adult patients diagnosed with ITP who received one or more medications to treat ITP. Patients less than 18 years old, pregnant, or with sustained platelet counts greater than 100 x 10 3 /µL throughout admission were excluded. Propensity score matching was used to estimate the protocol effect on primary and secondary outcomes.

Results

Of the 450 patients screened, 168 met inclusion criteria, with 115 patients assigned to the pre-protocol arm and 53 patients assigned post-protocol. In the pre-protocol cohort, 53 propensity-matched pairs were evaluated. The median drug cost of treatment was significantly higher in the pre- protocol arm compared with post-protocol ($24 899 vs $13 833; P < 0.001). There was no difference in either secondary outcome of median length of hospital stay (5.5 vs 5.2 days; P = 0.987) or median platelet count at discharge (82 vs 72; P = 0.477). Conclusion and Relevance: Implementation of a standardized sequential ITP treatment protocol at a community hospital resulted in substantial cost savings while maintaining positive clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical ProtocolsPurpura, Thrombocytopenic, IdiopathicAdultAgedFemaleHumansMaleMiddle AgedAcute DiseaseDrug CostsHospitalizationLength of StayPlatelet CountRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

ITP treatment protocolclinical pharmacyclinical practice guidelinescorticosteroidsglucocorticoidshematologyimmune globulinimmune thrombocytopeniapharmacoeconomicsthrombopoietin receptor agonist

Autor:innen und Institutionen

  • Department of Pharmacy Services, Sarasota Memorial Health Care System, Sarasota Memorial Hospital, Sarasota, FL, USA.
  • Department of Pharmacy Services, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Department of Pharmacy Services, Duke University Hospital, Durham, NC, USA.

ORCID-Profile: Justin Presutto

Zitieren

APA

Presutto, J., Broomfield, A. R., Parsons, S., LaMarc, M., McMahon, A., & Magruder, B. (2026). Impact of a Treatment Protocol for Hospitalized Adults With Acute Immune Thrombocytopenia. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280251338604

Vancouver

Presutto J, Broomfield AR, Parsons S, LaMarc M, McMahon A, Magruder B. Impact of a Treatment Protocol for Hospitalized Adults With Acute Immune Thrombocytopenia. Annals of Pharmacotherapy. 2026. doi:10.1177/10600280251338604

BibTeX
@article{Presutto2026,
  author = {Presutto, Justin and Broomfield, Abby Rose and Parsons, Sierra and LaMarc, Morgan and McMahon, Andre and Magruder, Bren},
  title = {Impact of a Treatment Protocol for Hospitalized Adults With Acute Immune Thrombocytopenia},
  journal = {Annals of Pharmacotherapy},
  year = {2026},
  doi = {10.1177/10600280251338604}
}
Kostenlos starten →